Table 3.
Relationships of eGFR with annualized healthcare charges by multivariate linear regression in the full study sample (n = 1913)a
| Variables | Parameter Estimate ($ per year [SEM])b | P | Parameter Estimate ($ per year [SEM])c | P |
|---|---|---|---|---|
| Total Charges | ||||
| Intercept | −5886 (8537) | 0.49 | 3197 (8266) | 0.70 |
| Age (per year) | 579 (174) | 0.0009 | 301 (170) | 0.08 |
| Male gender | −107 (4134) | 0.98 | −2271 (3988) | 0.57 |
| eGFR | ||||
| >90 ml/min level | reference | reference | ||
| 61 to 90 ml/min level | 1866 (5656) | 0.74 | 3556 (5456) | 0.51 |
| 31 to 60 ml/min level | 7590 (6087) | 0.21 | 7738 (5869) | 0.19 |
| Per ml/min ≤30 | 5435 (449) | <0.0001 | 5316 (433) | <0.0001 |
| Diabetes mellitus | — | — | 27,847 (9292) | 0.0028 |
| Cardiovascular disease | — | — | 188,220 (15847) | <0.0001 |
| Diabetes–cardiovascular disease interaction | — | — | −185,935 (29767) | <0.0001 |
| Total Medical Charges | ||||
| Intercept | −6228 (8551) | 0.47 | 2791 (8281) | 0.74 |
| Age (per year) | 547 (174) | 0.0017 | 273 (170) | 0.11 |
| Male gender | −865 (4162) | 0.84 | −2981 (4015) | 0.46 |
| eGFR | ||||
| >90 ml/min level | reference | reference | ||
| 61 to 90 ml/min level | 2067 (5676) | 0.72 | 3702 (5476) | 0.50 |
| 31 to 60 ml/min level | 6292 (6096) | 0.30 | 6346 (5878) | 0.28 |
| Per ml/min ≤30 | 5332 (448) | <0.0001 | 5215 (433) | <0.0001 |
| Diabetes mellitus | — | — | 25,104 (9265) | 0.007 |
| Cardiovascular disease | — | — | 186,664 (15797) | <0.0001 |
| Diabetes–cardiovascular disease interaction | — | — | −184,495 (29667) | <0.0001 |
| Inpatient Charges | ||||
| Intercept | −3465 (27799) | 0.90 | 17,240 (26967) | 0.52 |
| Age (per year) | 1437 (520) | 0.006 | 998 (517) | 0.05 |
| Male gender | −4782 (14202) | 0.74 | −10,690 (13628) | 0.43 |
| eGFR | ||||
| >90 ml/min level | reference | reference | ||
| 61 to 90 ml/min level | 1262 (20653) | 0.95 | 680 (19776) | 0.97 |
| 31 to 60 ml/min level | −5328 (20169) | 0.79 | −11,895 (19331) | 0.54 |
| Per ml/min <30 | 783 (1164) | 0.50 | 563 (1114) | 0.61 |
| Diabetes mellitus | — | — | −18,965 (24284) | 0.44 |
| Cardiovascular disease | — | — | 176,913 (30285) | <0.0001 |
| Diabetes–cardiovascular disease interaction | — | — | −193,981 (53821) | 0.0004 |
| Outpatient Pharmacy Charges | ||||
| Intercept | 542 (712) | 0.45 | 674 (714) | 0.35 |
| Age (per year) | 41 (15) | 0.0045 | 35 (15) | 0.02 |
| Male gender | 581 (343) | 0.09 | 566 (343) | 0.10 |
| eGFR | ||||
| >90 ml/min level | reference | reference | ||
| 61 to 90 ml/min level | 18 (472) | 0.97 | 37 (471) | 0.94 |
| 31 to 60 ml/min level | 1491 (502) | 0.003 | 1514 (501) | 0.003 |
| Per ml/min ≤30 | 119 (37) | 0.001 | 118 (36) | 0.001 |
| Diabetes mellitus | — | — | 2484 (789) | 0.002 |
| Cardiovascular disease | — | — | 1066 (1341) | 0.43 |
| Diabetes–cardiovascular disease interaction | — | — | −1514 (2464) | 0.54 |
Charges were adjusted to the $2008 medical component of the Consumer Price Index.
Regression model among the full sample, excluding parameters for diabetes and cardiovascular disease.
Regression model among the full sample, including parameters for diabetes and cardiovascular disease.